A Clinical Trial of SIBP-A16 Injection in Healthy Adults

NCT07106918 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus (RSV)

Interventions

BIOLOGICAL: SIBP-A16 injection
BIOLOGICAL: Nirsevimab
OTHER: SIBP-A16 buffer solution

Sponsor

Shanghai Institute Of Biological Products